Search results
This article will review the pathophysiology, etiology, screening, and diagnosis of osteoporosis; selected professional guidelines and recommendations; nonpharmacological management; pharmacological options; and the cost-effectiveness of those options.
5 lis 2019 · Alendronate is an option for maintaining or increasing bone mass, whereas risedronate is preferred in men with osteoporosis. [1] Off-Label Uses. Alendronate is used as an off-label medication for the below-mentioned conditions.
Bisphosphonates (BPs) are a commonly used class of drugs for the treatment of bone disorders. An extensive review of BPs with their clinical efficacy and safety profile is unavailable. This study aimed to review the available literature on BPs, ...
13 lip 2020 · Comparison table: some drugs for postmenopausal osteoporosis. Med Lett Drugs Ther. 2020 Jul 13;62 (1546):e112-e114. Keywords: Aclasta; Actonel; Atelvia; Binosto; Boniva; Duavee; Duavive; Evenity; Forteo; Fosamax; Fosavance; Prolia; Reclast; abaloparatide; alendronate; bazedoxifene; calcitonin; denosumab; estrogens; ibandronate; osteoporosis;
Medscape - Osteoporosis-specific dosing for Fosamax, Binosto (alendronate), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and...
2 sty 2024 · In osteoporosis treatment studies alendronate sodium 10 mg/day decreased the markers of bone formation, osteocalcin and bone specific alkaline phosphatase by approximately 50%, and total serum alkaline phosphatase by approximately 25 to 30% to reach a plateau after 6 to 12 months.
This study provides the first economic analysis of an alendronate effervescent tablet, suggesting that Binosto ® represents a cost-effective strategy compared with
